iSpecimen, Inc. (ISPC)
iSpecimen has a market cap or net worth of $14.65 million. The enterprise value is -$5.35 million.
The latest earnings date was Thursday, August 4, 2022, before market open.
|Last Earnings Date||Aug 4, 2022|
iSpecimen has 8.88 million shares outstanding. The number of shares has increased by 447.33% in one year.
|Shares Change (YoY)||+447.33%|
|Shares Change (QoQ)||+0.64%|
|Owned by Insiders (%)||30.25%|
|Owned by Institutions (%)||4.65%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 13.37, with a Debt / Equity ratio of 0.15.
|Debt / Equity||0.15|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -138.90%.
|Return on Equity (ROE)||-36.20%|
|Return on Assets (ROA)||-29.40%|
|Return on Capital (ROIC)||-138.90%|
|Revenue Per Employee||$171,610|
|Profits Per Employee||-$145,660|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-73.17%|
|50-Day Moving Average||2.10|
|200-Day Moving Average||2.78|
|Average Volume (30 Days)||404,306|
Short Selling Information
The latest short interest is 106,657, so 1.20% of the outstanding shares have been sold short.
|Short % of Shares Out||1.20%|
|Short % of Float||1.74%|
|Short Ratio (days to cover)||1.82|
In the last 12 months, iSpecimen had revenue of $10.12 million and -8.59 million in losses. Earnings per share was $2.11.
|Earnings Per Share (EPS)||$2.11|
The company has $23.69 million in cash and $3.69 million in debt, giving a net cash position of $20.00 million or $2.25 per share.
|Cash & Cash Equivalents||23.69M|
|Net Cash Per Share||$2.25|
|Book Value Per Share||2.85|
In the last 12 months, operating cash flow was -$10.75 million and capital expenditures -$1.37 million, giving a free cash flow of -$12.13 million.
|Operating Cash Flow||-10.75M|
|Free Cash Flow||-12.13M|
|FCF Per Share||n/a|
Gross margin is 57.51%, with operating and profit margins of -81.02% and -84.88%.
Dividends & Yields
iSpecimen does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for iSpecimen is $10.03, which is 507.88% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||507.88%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|